Trials Sponsors Conditions Drugs Pricing

Conditions

HIV Lipodystrophy Syndrome HIV/AIDS

Keywords

energy expendituredoubly labeled wateraccelerometerHIVlipodystrophy syndrome.

Outcome Measures

Primary Outcomes (2)

Total Energy Expenditure (kcal/d)
14 day
Resting Energy Expenditure (kcal/d)
1 day

Secondary Outcomes (1)

Correlation between doubly labeled water and accelerometer to measure total energy expenditure (ICC, 95% CI)
14 days

Study Arms (3)

LIPO-HIPO-

HIV-seropositive without lipodystrophy and no use of lipid-lowering drugs.

LIPO+HIPO-

HIV-seropositive with lipodystrophy and no use of lipid-lowering drugs.

LIPO+HIPO+

HIV-seropositive with lipodystrophy and use of lipid-lowering drugs.

Drug: use of lipid-lowering drugs.

Interventions

use of lipid-lowering drugs.Drug

The patients shoud be in use of a lipid-lowering drugs previouly, at least one month before of the begining of the study.

Also known as: statins and fibrates

LIPO+HIPO+

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexmale

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

Men previously diagnosed with HIV infection, on antiretroviral therapy.

You may qualify if:

Use of antiretroviral therapy for at least 4 months

Sponsors & Collaborators

University of Sao Paulo General Hospital
Otherlead
Fundação de Amparo à Pesquisa do Estado de São Paulo
Governmentcollaborator

Biospecimen

Retention: SAMPLES WITH DNA

urine.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV-Associated Lipodystrophy Syndrome

Interventions

Hydroxymethylglutaryl-CoA Reductase InhibitorsFibric Acids

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus Infections

Enrollment

45 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 4, 2015

First Posted

August 21, 2015

Study Start

March 2013

Date type not reported

This date has not been verified as actual or estimated.

Energy Expenditure of People Living With HIV/AIDS

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (3)

LIPO-HIPO-

LIPO+HIPO-

LIPO+HIPO+

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (3)

LIPO-HIPO-

LIPO+HIPO-

LIPO+HIPO+

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Source record